CY1739A - Piperazinecarboxylic acid its preparation and pharmaceutical compositions containing it - Google Patents
Piperazinecarboxylic acid its preparation and pharmaceutical compositions containing itInfo
- Publication number
- CY1739A CY1739A CY173995A CY173995A CY1739A CY 1739 A CY1739 A CY 1739A CY 173995 A CY173995 A CY 173995A CY 173995 A CY173995 A CY 173995A CY 1739 A CY1739 A CY 1739A
- Authority
- CY
- Cyprus
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- piperazinecarboxylic acid
- piperazinecarboxylic
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- RFIOZSIHFNEKFF-UHFFFAOYSA-N piperazine-1-carboxylic acid Chemical compound OC(=O)N1CCNCC1 RFIOZSIHFNEKFF-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB878703749A GB8703749D0 (en) | 1987-02-18 | 1987-02-18 | Piperazinecarboxylic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1739A true CY1739A (en) | 1995-10-20 |
Family
ID=10612501
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY173995A CY1739A (en) | 1987-02-18 | 1995-10-20 | Piperazinecarboxylic acid its preparation and pharmaceutical compositions containing it |
Country Status (28)
| Country | Link |
|---|---|
| JP (1) | JPH0723387B2 (fr) |
| KR (1) | KR960015190B1 (fr) |
| AT (1) | AT391320B (fr) |
| AU (1) | AU613009B2 (fr) |
| BE (1) | BE1002427A3 (fr) |
| CA (1) | CA1327799C (fr) |
| CH (1) | CH675125A5 (fr) |
| CY (1) | CY1739A (fr) |
| DE (1) | DE3804936C2 (fr) |
| DK (1) | DK168441B1 (fr) |
| ES (2) | ES2011319A6 (fr) |
| FI (1) | FI86733C (fr) |
| FR (1) | FR2610932B1 (fr) |
| GB (2) | GB8703749D0 (fr) |
| GR (1) | GR1002471B (fr) |
| HK (1) | HK142093A (fr) |
| HU (2) | HU199858B (fr) |
| IE (1) | IE59098B1 (fr) |
| IL (1) | IL85436A0 (fr) |
| IT (1) | IT1219447B (fr) |
| LU (1) | LU87129A1 (fr) |
| MY (1) | MY103206A (fr) |
| NL (1) | NL8800412A (fr) |
| NZ (1) | NZ223529A (fr) |
| PH (1) | PH25512A (fr) |
| PT (1) | PT86776B (fr) |
| SE (1) | SE467256B (fr) |
| ZA (1) | ZA881146B (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU202111B (en) * | 1988-03-11 | 1991-02-28 | Sandoz Ag | Process for producing pharmaceutical compositions containing (r)-(e)-4--(3-phosphono-2-propenyl)-2-piperazine-carboxylic acid as active component |
| US5086072A (en) * | 1990-06-18 | 1992-02-04 | The United States Of America As Represented By The Department Of Health And Human Services | Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex |
| EP0488959A3 (en) * | 1990-11-28 | 1992-08-05 | Sandoz Ltd. | New uses of competitive nmda receptor antagonists |
| US5260286A (en) * | 1992-10-16 | 1993-11-09 | Japan Tobacco, Inc. | 2-piperidinecarboxylic acid derivatives useful as NMDA receptor antagonists |
| JPH11508761A (ja) * | 1995-05-08 | 1999-08-03 | ロンザ アーゲー | Ｒ−α−ピペラジンカルボン酸およびＳ−α−ピペラジンカルボキサミドを製造する生物工学的方法 |
| US6071915A (en) | 1997-05-12 | 2000-06-06 | Ortho-Mcneil Pharmaceutical, Inc. | Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia |
| GB9821179D0 (en) * | 1998-09-30 | 1998-11-25 | Merck Sharp & Dohme | Therapeutic use |
| JP2008124531A (ja) | 2006-11-08 | 2008-05-29 | Nec Electronics Corp | 半導体装置およびオーディオプロセッサチップ |
| EP3427729A1 (fr) | 2017-07-13 | 2019-01-16 | Paris Sciences et Lettres - Quartier Latin | Probénécide destiné à être utilisé dans le traitement de maladies, troubles ou états épileptiques |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1248531A (fr) * | 1984-04-17 | 1989-01-10 | Jeffrey C. Watkins | Derives de substitution en 4 d'acides piperazine-2- carboxyliques |
-
1987
- 1987-02-18 GB GB878703749A patent/GB8703749D0/en active Pending
-
1988
- 1988-02-11 LU LU87129A patent/LU87129A1/fr unknown
- 1988-02-12 IT IT47631/88A patent/IT1219447B/it active
- 1988-02-12 BE BE8800177A patent/BE1002427A3/fr active
- 1988-02-12 FR FR888801782A patent/FR2610932B1/fr not_active Expired - Lifetime
- 1988-02-15 MY MYPI88000155A patent/MY103206A/en unknown
- 1988-02-15 GB GB8803438A patent/GB2201676B/en not_active Expired - Lifetime
- 1988-02-16 CA CA000559170A patent/CA1327799C/fr not_active Expired - Fee Related
- 1988-02-16 AU AU11758/88A patent/AU613009B2/en not_active Ceased
- 1988-02-16 NZ NZ223529A patent/NZ223529A/xx unknown
- 1988-02-16 IL IL85436A patent/IL85436A0/xx not_active IP Right Cessation
- 1988-02-16 IE IE41388A patent/IE59098B1/en not_active IP Right Cessation
- 1988-02-16 CH CH549/88A patent/CH675125A5/de not_active IP Right Cessation
- 1988-02-16 HU HU88746A patent/HU199858B/hu not_active IP Right Cessation
- 1988-02-16 DK DK079688A patent/DK168441B1/da not_active IP Right Cessation
- 1988-02-16 PH PH36514A patent/PH25512A/en unknown
- 1988-02-16 GR GR880100084A patent/GR1002471B/el not_active IP Right Cessation
- 1988-02-17 KR KR1019880001680A patent/KR960015190B1/ko not_active IP Right Cessation
- 1988-02-17 FI FI880744A patent/FI86733C/fi not_active IP Right Cessation
- 1988-02-17 DE DE3804936A patent/DE3804936C2/de not_active Expired - Fee Related
- 1988-02-17 AT AT0036788A patent/AT391320B/de not_active IP Right Cessation
- 1988-02-17 JP JP63036458A patent/JPH0723387B2/ja not_active Expired - Lifetime
- 1988-02-17 SE SE8800541A patent/SE467256B/sv not_active IP Right Cessation
- 1988-02-17 PT PT86776A patent/PT86776B/pt not_active IP Right Cessation
- 1988-02-18 NL NL8800412A patent/NL8800412A/nl not_active Application Discontinuation
- 1988-02-18 ZA ZA881146A patent/ZA881146B/xx unknown
- 1988-02-18 ES ES888800466A patent/ES2011319A6/es not_active Expired - Lifetime
-
1989
- 1989-10-16 ES ES8903482A patent/ES2021904A6/es not_active Expired - Lifetime
-
1993
- 1993-12-30 HK HK1420/93A patent/HK142093A/xx not_active IP Right Cessation
-
1995
- 1995-06-09 HU HU95P/P00176P patent/HU211269A9/hu unknown
- 1995-10-20 CY CY173995A patent/CY1739A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL82221A0 (en) | Phenyl-piperazines and pharmaceutical compositions containing them | |
| GR871659B (en) | Substituted a-aminoacids their preparation and pharmaceutical compositions containing them | |
| IL85896A (en) | Substituted di-tert.- butylphenols and pharmaceutical compositions containing them | |
| NZ226002A (en) | Peptidylheterocyclic compounds and pharmaceutical compositions | |
| IL88433A0 (en) | Diarylstyrylquinoline diacids and pharmaceutical compositions containing them | |
| IL85969A0 (en) | Ribofuranuronic acid derivatives and pharmaceutical compositions containing them | |
| IL84268A (en) | Amino-cyclohexyl-hydroxyalkanoic acid peptide derivatives and pharmaceutical compositions containing them | |
| IL87800A0 (en) | Dioxolane-2-carboxylic acids and pharmaceutical compositions comprising them | |
| IL79025A0 (en) | Quinolonecarboxylic acid esters,their preparation and pharmaceutical compositions containing them | |
| IL87644A0 (en) | Oxadiazolyl-azabicycloheptanes,their preparation and pharmaceutical compositions containing them | |
| NZ226450A (en) | Crystalline-1-carbacephalosporin and pharmaceutical compositions | |
| IL77849A0 (en) | Aryldihydropyridinedicarboxylic acid ester derivatives,their preparation and pharmaceutical compositions containing them | |
| CY1739A (en) | Piperazinecarboxylic acid its preparation and pharmaceutical compositions containing it | |
| IL84808A (en) | Furanuronic acid derivatives,their preparation and pharmaceutical compositions containing them | |
| NZ224923A (en) | 2-methoxymethyl-penem-3-carboxylic acid derivatives and pharmaceutical compositions | |
| EP0191735A3 (en) | Novel oxaluric acid derivatives and pharmaceutical compositions containing them | |
| IL86926A0 (en) | 1h-pyrazole-1-alkanamides,their preparation and pharmaceutical compositions containing them | |
| NZ221018A (en) | 2-penem-3-carboxylic acid derivatives and pharmaceutical compositions | |
| IL93590A0 (en) | Acid addition salts of naphthalenmethanamino and pharmaceutical compositions containing them | |
| IL77799A0 (en) | Dihydropyridinedicarboxylic acid ester derivatives,their preparation and pharmaceutical compositions containing them | |
| CY1752A (en) | 8a-Acylaminoergoline its preparation and pharmaceutical compositions containing it | |
| PH24338A (en) | Nitroapovincaminic acid derivatives and pharmaceutical compositions containing them | |
| IL85824A (en) | Pyrrolealdehydes,their preparation and pharmaceutical compositions containing them | |
| IL85524A0 (en) | Heterocyclyl-2-propyn-1-amines and pharmaceutical compositions containing same | |
| GR861633B (en) | Novel 11- methylene -oestr-15-enes preparation process and pharmaceutical compositions comprising these compounds |